News

As an undercover investigator in the New York Police Department's organized crime unit, Christian Saffran had a...

Abimbola Ayangbesan '18 has received the Ferdinand C. Valentine Medical Student Research Grant in Urology from The New York Academy of Medicine.

NewYork-Presbyterian/Queens continues to grow its leading cardiothoracic surgery practice centered on precision medicine and minimally-invasive surgery.

Tri-I student Gustav Cederquist has received an honorable mention from Regeneron Pharmaceuticals Inc. for the Regeneron Prize for Creative Innovation.

A physician-entrepreneur aims to make surgery safer in the developing world.

Weill Cornell Medicine and NewYork-Presbyterian investigators are enrolling subjects for a phase I clinical trial to establish safety, proper dosing and preliminary efficacy.

Two Weill Cornell Medicine scientists have received the Damon Runyon Cancer Research Clinical Investigator Award for their innovative research.

Awards, honors, prizes and achievements for the week of July 29 - August 5

Scientists have identified a critical function of a protein that is a frequent indicator of cancer when the protein is in its mutated state.

Two of Weill Cornell Medicine's partners are among the nation's elite hospitals, landing on U.S. News and World Report's "Best Hospitals" Honor Roll.

U.S. News & World Report survey recognizes NewYork-Presbyterian for its excellence in numerous specialties.

Group plans to promote and conduct research across countries to better understand the problem.

Awards, honors, prizes and achievements for the week of July 22 - July 29.

Oncologist Dr. Silvia Formenti has spent her career in medicine fighting for those with incurable diseases.

Quitting cigarettes may not improve smokers' lung function if they have already begun to develop chronic obstructive pulmonary disease.

Dramatic expansion of telemedicine the result of philanthropic partnership with Rita E. Hauser and Gustave M. Hauser.

Awards, honors, prizes and achievements for the week of July 15 - July 22.

A powerful next-generation genome-sequencing test developed at Weill Cornell Medicine can detect mutations that guide precision cancer treatment with over 95 percent accuracy.

Inflammatory cells in the lungs of premature infants receiving oxygen contribute to the development of chronic lung problems.

People are the heart and soul of Weill Cornell Medicine, driving our efforts to advance healthcare and biomedical science and inspiring us in our endeavors every day. A new multimedia campaign, called We Are Weill Cornell Medicine, celebrates the people who make the institution special.